1-3 of 3
Bruno Cassinat, Pharm.D
Close
Sort by
Journal Articles

Interferon-Alpha Preferentially Targets JAK2V617F-Positive Rather Than Wild-Type Early Progenitor Cells in Myeloproliferative Disorders.

Florence Pasquier, Carole Tonetti, Rodolphe Besancenot, Bruno Cassinat, Pharm.D, Jean-Jacques Kiladjian, MD, PhD, Olivier Herault, MD, PhD, MSc, Philippe Rameau, Catherine Lacout, Jean-Luc Villeval, William Vainchenker, MD, PhD, Ronan Chaligné, Stephane Giraudier
Journal: Blood
Blood (2009) 114 (22): 436.
https://doi.org/10.1182/blood.V114.22.436.436
Published: 2009
Journal Articles

Human Adenylate Kinase 2 Deficiency Inhibits Hematopoietic Cell Differentiation towards Neutrophil and T Lymphoid Lineages.

Emmanuelle M. Six, PhD, Chantal Lagresle-Peyrou, PhD, Corinne Demerens-deChappedelaine, PhD, Frederic Rieux-Laucat, PhD, Andrea Didati, PhD, Marie-Claude Stolzenberg, Bruno Cassinat, Pharm.D, Christine Chomienne, MD, PhD, Alain Fischer, MD, PhD, Marina Cavazzana-Calvo, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 78.
https://doi.org/10.1182/blood.V114.22.78.78
Published: 2009
Journal Articles

Abnormal Expression and Function of the Lnk Adaptor Protein in Myeloproliferative Neoplasms (MPN).

Jean-Jacques Kiladjian, MD, PhD, Fanny Baran-Marszak, MD, PhD, Christophe Desterke, PhD, Bruno Cassinat, Pharm.D, Hajer Magdoud, Elisabeth Mazoyer, MD, Pierre Fenaux, MD, PhD, Claude Gardin, Florence Cymbalista, MD, PhD, Marie-Caroline Le Bousse-Kerdiles, PhD, Nadine Varin-Blank, PhD, Laura Velazquez, PhD
Journal: Blood
Blood (2009) 114 (22): 2897.
https://doi.org/10.1182/blood.V114.22.2897.2897
Published: 2009